The largest database of trusted experimental protocols

Multiplex elisa based assay

Manufactured by Mesoscale

The Multiplex ELISA-based assay is a laboratory equipment product that allows for the simultaneous detection and quantification of multiple analytes in a single sample. It utilizes the enzyme-linked immunosorbent assay (ELISA) technique to measure the concentration of various target molecules, such as proteins, peptides, or hormones, in a sample.

Automatically generated - may contain errors

Lab products found in correlation

3 protocols using multiplex elisa based assay

1

Quantifying Intestinal Biomarkers via ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum levels of intestinal-fatty acid binding protein (I-FABP), sCD14, and sCD163 were quantified using ELISA (Quantikine ELISA kit, R&D systems) while sICAM-1 and sVCAM-1 were measured using multiplex ELISA-based assay (Meso-Scale Discovery). Assays were performed in the same UW laboratory in duplicate. The inter-assay coefficients of variation were <11%.
+ Open protocol
+ Expand
2

Multiplex Analysis of Plasma Immune Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma levels of IL-2, IL-4, IL-5, IL-6, IL-2p70, IL-13, IL-15, IL-17A, IFN-γ, and TNF-α were measured using the multiplex ELISA-based assay (Meso-Scale Discovery). Samples with a coefficient of variation greater than 30% were re-ran. Plasma biomarkers of intestinal barrier dysfunction (intestinal-fatty acid binding protein [I-FABP]) and monocyte/macrophage activation markers (soluble CD14) were quantified using ELISA (Quantikine ELISA kit, R&D systems). Assays were performed in duplicate and in accordance with manufacturers’ protocols.
+ Open protocol
+ Expand
3

Plasma Cytokine and Intestinal Barrier Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma levels of IL-2, IL-4, IL-5, IL-6, IL-2p70, IL-13, IL-15, IL-17A, IFN-γ, and TNF-α were measured using the multiplex ELISA-based assay (Meso-Scale Discovery). Samples with a coefficient of variation >30% were re-ran. Plasma biomarkers of intestinal barrier dysfunction [intestinal-fatty acid binding protein (I-FABP)] and monocyte/macrophage activation markers (soluble CD14) were quantified using ELISA (Quantikine ELISA kit, R&D Systems). Assays were performed in duplicate and in accordance with manufacturers’ protocols.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!